No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer

Breast Cancer Research

Volumn 4, Issue 6, 2002, Pages

  Spurdle, Amanda B ^a   Hopper, John L ^b   Chen, Xiaoqing ^a   McCredie, Margaret R E ^c,d   Giles, Graham G ^e   Newman, Beth ^f   Chenevix Trench, Georgia ^a   Khanna, KumKum ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Epidemiology Unit   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e CANCER EPIDEMIOLOGY CENTRE   (Australia)

^f QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Ataxia telangiectasia mutated gene; Breast cancer; Variant

Indexed keywords

ATM PROTEIN; ATM PROTEIN, HUMAN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

5' EXONUCLEASE ASSAY; ADULT; AGE DISTRIBUTION; AMINO ACID SUBSTITUTION; ARTICLE; ATM GENE; ATTRIBUTABLE RISK; AUSTRALIAN; BIOASSAY; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC RISK; GENETIC VARIATION; GENOTYPE; HARDY WEINBERG EQUILIBRIUM; HETEROZYGOTE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; INTERMEDIATE RISK POPULATION; MAJOR CLINICAL STUDY; POPULATION RESEARCH; ALLELE; BREAST NEOPLASMS; GENETIC POLYMORPHISM; GENETICS; RISK;

ALLELES; AMINO ACID SUBSTITUTION; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; HUMANS; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RISK; TUMOR SUPPRESSOR PROTEINS;

EID: 34247625921     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr534     Document Type: Article

References (13)

1. Kerr P, Ashworth A: New complexities for BRCA1 and BRCA2. Curr Biol. 2001, 11: R668-R676. 10.1016/S0960-9822(01)00389-X.
2. Khanna K, Jackson SP: DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001, 27: 247-254. 10.1038/85798.
3. Swift M: Public health burden of cancer in ataxia-telangiectasia heterozygotes. J Natl Cancer Inst. 2001, 93: 84-85. 10.1093/jnci/93.2.84.
4. Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA, Scott C, Pupo GM, Dork T, Bendix R, Kirk J, Tucker K, McCredie MR, Hopper JL, Sambrook J, Mann GJ, Khanna KK: Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst. 2002, 94: 205-215. 10.1093/jnci/94.3.205.
5. Teraoka SN, Malone KE, Doody DR, Suter NM, Ostrander EA, Daling JR, Concannon P: Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer. 2001, 92: 479-487. 10.1002/1097-0142(20010801)92:3<479::AID-CNCR1346>3.0.CO;2-G.
6. Dork T, Bendix R, Bremer M, Rades D, Klopper K, Nicke M, Skawran B, Hector A, Yamini P, Steinmann D, Weise S, Stuhrmann M, Karstens JH: Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res. 2001, 61: 7608-7615.
7. Sommer SS, Buzin CH, Jung M, Zheng J, Liu Q, Jeong SJ, Moulds J, Nguyen VQ, Feng J, Bennett WP, Dritschilo A: Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controls. Cancer Genet Cytogenet. 2002, 134: 25-32. 10.1016/S0165-4608(01)00594-5.
8. Larson GP, Zhang G, Ding S, Foldenauer K, Udar N, Gatti R, Neuberg D, Lunetta K, Ruckdeschel JC, Longmate J, Flanagan S, Krontiris TG: An allelic variant at the ATM locus is implicated in breast cancer susceptibility. Genet Test. 1997, 1: 165-170.
9. Hopper JL, Giles GG, McCredie MRE, Boyle P: Background, rationale and protocol for a case-control-family study of breast cancer. The Breast. 1994, 3: 79-86.
10. Hopper JL, Chenevix-Trench G, Jolley DJ, Dite GS, Jenkins MA, Venter DJ, McCredie MRE, Giles GG: Design and analysis issues in a population-based case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr. 1999, 26: 95-100.
11. McCredie MR, Dite GS, Giles GG, Hopper JL: Breast cancer in Australian women under the age of 40. Cancer Causes Control. 1998, 9: 189-198. 10.1023/A:1008886328352.
12. Southey MC, Batten LE, McCredie MRE, Giles GG, Dite G, Hopper JL, Venter DJ: Estrogen receptor polymorphism at codon 325 and risk of breast cancer in women before age forty. J Natl Cancer Inst. 1998, 90: 532-536. 10.1093/jnci/90.7.532.
13. Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G: The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiol Biomarkers Prev. 2002, 11: 439-443.